Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Alexion Aims To Drive PNH Diagnoses (And Soliris Sales) With Diagnostic

Sep 03 2007

• By Bridget Silverman

Related Content

Alexion’s Soliris Blood Treatment Will Cost Almost $400,000 Per Year

Apr 02 2007

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window